Clearpoint Neuro Share Price (NASDAQ: CLPT)

$10.53

▲

-0.11

(-1.03%)

Live

Last updated on August 28, 2025 at 11:38 pm IST

$₹

Check the interactive Clearpoint Neuro Stock chart to analyse performance

Clearpoint Neuro stock performance

as on August 28, 2025 at 11:38 pm IST

Today's Low:$10.48
Today's High:$10.70
$10.53
0.47%
Downside
Day's Volatility :2.06%
Upside
1.59%
52 Weeks Low:$9.76
52 Weeks High:$19.22
$10.53
7.31%
Downside
52 Weeks Volatility :49.22%
Upside
45.21%

Clearpoint Neuro Stock Returns

Period	Clearpoint Neuro Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-11.11%	4.2%	0.0%
6 Months	-25.1%	-8.0%	0.0%
1 Year	-15.29%	-12.1%	0.0%
3 Years	-17.07%	7.6%	-6.9%

Clearpoint Neuro Inc Key Stats

Check Clearpoint Neuro key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$10.64
Open	$10.645
Today's High	$10.7
Today's Low	$10.48
Market Capitalization	$302.5M
Today's Volume	$135.2K
52 Week High	$19.22
52 Week Low	$9.76
Revenue TTM	$33.6M
EBITDA	$-21.6M
Earnings Per Share (EPS)	$-0.8
Profit Margin	-66.15%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-85.68%

Stock Returns calculator for Clearpoint Neuro Stock including INR - Dollar returns

The Clearpoint Neuro stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Clearpoint Neuro investment value today

Current value as on today

₹88,197

Returns

₹11,803

(-11.8%)

Returns from Clearpoint Neuro Stock

₹16,162 (-16.16%)

Dollar Returns*

₹4,360 (+4.36%)

Indian investors sentiment towards Clearpoint Neuro Stock

51.08%

Period: Jul 28, 2025 to Aug 27, 2025. Change in 30 Days versus previous period

Investment in Clearpoint Neuro Shares from India has grown by 51.08% over the past 30 days, indicating increased transactional activity.

13%

Period: Jul 28, 2025 to Aug 27, 2025. Change in 30 Days versus previous period

Search interest for Clearpoint Neuro Stock from India on INDmoney has increased by 13% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Clearpoint Neuro Inc

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
5.19%
Millennium Management LLC
2.61%
Susquehanna International Group, LLP
1.70%
BlackRock Inc
1.45%
Brown Advisory Holdings Inc
1.16%
Essex Investment Management Company, LLC
1.14%

Analyst Recommendation on Clearpoint Neuro Stock

Rating

Trend

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Clearpoint Neuro(by analysts ranked 0 to 5 stars)

Clearpoint Neuro Share Price Target

What analysts predicted

Upside of 175.4%

Target:

$29.00

Current:

$10.53

Clearpoint Neuro share price target is $29.00, a slight Upside of 175.4% compared to current price of $10.53 as per analysts' prediction.

Clearpoint Neuro Stock Insights

Price Movement
In the last 3 months, CLPT stock has moved down by -12.0%
Increasing Revenue
Revenue is up for the last 3 quarters, 7.77M → 9.21M (in $), with an average increase of 8.2% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -6.02M → -5.83M (in $), with an average increase of 3.2% per quarter
CLPT vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 33.1% return, outperforming this stock by 48.4%
CLPT vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 161.3% return, outperforming this stock by 178.2%
Price to Sales
ForCLPT every $1 of sales, investors are willing to pay $8.8, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Clearpoint Neuro Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$11.2M	↑ 52.54%
Net Income	$-5.5M	↓ 10.12%
Net Profit Margin	-49.39%	↑ 34.43%

	FY20	Y/Y Change
Revenue	$12.8M	↑ 14.37%
Net Income	$-6.8M	↑ 22.42%
Net Profit Margin	-52.86%	↓ 3.47%

	FY21	Y/Y Change
Revenue	$16.3M	↑ 27.05%
Net Income	$-14.4M	↑ 112.47%
Net Profit Margin	-88.41%	↓ 35.55%

	FY22	Y/Y Change
Revenue	$20.6M	↑ 26.09%
Net Income	$-16.4M	↑ 14.05%
Net Profit Margin	-79.97%	↑ 8.44%

	FY23	Y/Y Change
Revenue	$24.0M	↑ 16.56%
Net Income	$-22.1M	↑ 34.4%
Net Profit Margin	-92.21%	↓ 12.24%

	FY24	Y/Y Change
Revenue	$31.4M	↑ 31.04%
Net Income	$-18.9M	↓ 14.37%
Net Profit Margin	-60.25%	↑ 31.96%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$7.6M	↑ 12.17%
Net Income	$-4.1M	↓ 10.24%
Net Profit Margin	-54.27%	↑ 13.56%

	Q2 FY24	Q/Q Change
Revenue	$7.9M	↑ 2.87%
Net Income	$-4.4M	↑ 6.32%
Net Profit Margin	-56.1%	↓ 1.83%

	Q3 FY24	Q/Q Change
Revenue	$8.1M	↑ 3.36%
Net Income	$-5.0M	↑ 12.84%
Net Profit Margin	-61.24%	↓ 5.14%

	Q4 FY24	Q/Q Change
Revenue	$7.8M	↓ 4.32%
Net Income	$-5.4M	↑ 8.28%
Net Profit Margin	-69.31%	↓ 8.07%

	Q1 FY25	Q/Q Change
Revenue	$8.5M	↑ 9.19%
Net Income	$-6.0M	↑ 11.88%
Net Profit Margin	-71.02%	↓ 1.71%

	Q2 FY25	Q/Q Change
Revenue	$9.2M	↑ 8.6%
Net Income	$-5.8M	↓ 3.14%
Net Profit Margin	-63.34%	↑ 7.68%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$7.4M	↑ 50.08%

	FY20	Y/Y Change
Profit	$9.1M	↑ 23.51%

	FY21	Y/Y Change
Profit	$11.3M	↑ 23.8%

	FY22	Y/Y Change
Profit	$13.5M	↑ 19.84%

	FY23	Y/Y Change
Profit	$13.6M	↑ 0.61%

	FY24	Y/Y Change
Profit	$19.1M	↑ 40.46%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$4.5M	↑ 12.76%

	Q2 FY24	Q/Q Change
Profit	$5.0M	↑ 10.23%

	Q3 FY24	Q/Q Change
Profit	$4.8M	↓ 2.83%

	Q4 FY24	Q/Q Change
Profit	$4.8M	↓ 1.75%

	Q1 FY25	Q/Q Change
Profit	$5.1M	↑ 7.77%

	Q2 FY25	Q/Q Change
Profit	$5.6M	↑ 8.26%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-2.8M	↓ 38.46%
Investing Cash Flow	$-160.2K	↑ 152.31%
Financing Cash Flow	$5.6M	↓ 474.97%

	FY20	Y/Y Change
Operating Cash Flow	$-7.8M	↑ 174.01%
Investing Cash Flow	$-482.0K	↑ 200.89%
Financing Cash Flow	$22.7M	↑ 304.92%

	FY21	Y/Y Change
Operating Cash Flow	$-12.7M	↑ 62.62%
Investing Cash Flow	$-168.0K	↓ 65.15%
Financing Cash Flow	$46.9M	↑ 106.56%

	FY22	Y/Y Change
Operating Cash Flow	$-16.2M	↑ 27.33%
Investing Cash Flow	$-10.7M	↑ 6290.48%
Financing Cash Flow	$409.0K	↓ 99.13%

	FY23	Y/Y Change
Operating Cash Flow	$-13.7M	↓ 15.14%
Investing Cash Flow	$8.9M	↓ 183.36%
Financing Cash Flow	$296.0K	↓ 27.63%

	FY24	Y/Y Change
Operating Cash Flow	$-9.0M	↓ 34.77%
Investing Cash Flow	$-275.0K	↓ 103.07%
Financing Cash Flow	$6.2M	↑ 1990.88%

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-1.2M	↓ 55.06%
Investing Cash Flow	$-12.0K	-
Financing Cash Flow	$-10.1M	↓ 6388.12%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-1.2M	↑ 3.67%
Investing Cash Flow	$-263.0K	↑ 2091.67%
Financing Cash Flow	$37.0K	↓ 100.37%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-6.2M	↑ 396.54%
Investing Cash Flow	$-183.0K	↓ 30.42%
Financing Cash Flow	$-1.4M	↓ 3781.08%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-2.6M	↓ 58.65%
Investing Cash Flow	$-91.0K	↓ 50.27%
Financing Cash Flow	$32.0M	↓ 2447.8%

Clearpoint Neuro Technicals Summary

Sell

Neutral

Buy

Clearpoint Neuro is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Clearpoint Neuro Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Clearpoint Neuro Inc	0.85%	-25.1%	-15.29%	-17.07%	-42.36%
Medtronic Plc	-0.42%	1.44%	4.21%	3.53%	-14.35%
Edwards Lifesciences Corp.	0.53%	13.31%	17.84%	-10.47%	-5.75%
Boston Scientific Corp.	-0.56%	5.03%	33.14%	162.12%	158.09%
Stryker Corporation	-1.85%	1.09%	10.39%	90.11%	98.4%
Abbott Laboratories	2.7%	-3.25%	16.44%	29.08%	20.09%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Clearpoint Neuro Inc	NA	NA	NA	-0.8	-0.86	-0.25	NA	0.7
Medtronic Plc	25.61	25.61	2.16	5.46	0.1	0.04	0.03	37.46
Edwards Lifesciences Corp.	33.85	33.85	4.85	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	63.33	63.33	1.85	2.98	0.12	0.05	NA	15.14
Stryker Corporation	52.37	52.37	2.24	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.55	16.55	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Clearpoint Neuro Inc	Buy	$302.5M	-42.36%	NA	-66.15%
Medtronic Plc	Buy	$118.8B	-14.35%	25.61	13.63%
Edwards Lifesciences Corp.	Buy	$47.5B	-5.75%	33.85	72.96%
Boston Scientific Corp.	Buy	$157.6B	158.09%	63.33	13.55%
Stryker Corporation	Buy	$150.8B	98.4%	52.37	12.25%
Abbott Laboratories	Buy	$229.5B	20.09%	16.55	32.43%

About Clearpoint Neuro Inc

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V.; UCB Biopharma SRL; NE Scientific, LLC; and University of California, San Francisco, and Johns Hopkins University. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Organization	Clearpoint Neuro
Employees	115
CEO	Mr. Joseph Michael Burnett
Industry	Health Technology

Key Management of Clearpoint Neuro Inc

Name	Title
Mr. Joseph Michael Burnett	President, CEO & Director
Mr. Danilo D'Alessandro	Chief Financial Officer
Mr. Jeremy L. Stigall	Chief Business Officer
Mr. Mazin Sabra	Chief Operating Officer
Ms. Ellisa Cholapranee J.D.	General Counsel & Secretary

Important FAQs about investing in CLPT Stock from India :

What is Clearpoint Neuro share price today?

Clearpoint Neuro share price today is $10.53 as on August 28, 2025 at 11:38 pm IST. Clearpoint Neuro share today touched a day high of $10.70 and a low of $10.48.

What is the 52 week high and 52 week low for Clearpoint Neuro share?

Clearpoint Neuro share touched a 52 week high of $19.22 and a 52 week low of $9.76. Clearpoint Neuro stock price today i.e. August 28, 2025 at 11:38 pm IST is trending at $10.53, lower by 45.21% versus the 52 week high.

How to invest in Clearpoint Neuro Stock (CLPT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Clearpoint Neuro on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Clearpoint Neuro Shares that will get you 0.1425 shares as per Clearpoint Neuro share price of $10.53 per share as on August 28, 2025 at 11:38 pm IST.

What is the minimum amount required to buy Clearpoint Neuro Stock (CLPT) from India?

Indian investors can start investing in Clearpoint Neuro (CLPT) shares with as little as ₹87.587 or $1 (as of August 28, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.87 in Clearpoint Neuro stock (as per the Rupee-Dollar exchange rate as on August 28, 2025). Based on Clearpoint Neuro share’s latest price of $10.53 as on August 28, 2025 at 11:38 pm IST, you will get 0.9497 shares of Clearpoint Neuro. Learn more about fractional shares .

What are the returns that Clearpoint Neuro has given to Indian investors in the last 5 years?

Clearpoint Neuro stock has given -42.36% share price returns and 18.52% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?